Leukemia Clinical Trials

Trials for someone you care about with leukemia.

Cancer

RecruitingDrugDeviceBehavioralOlder adultsHealthy volunteers

39 trials · showing 30

Comparing Biospecimen Collection with Bone Marrow Aspiration for chronic lymphocytic leukemia

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives one or more of: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Obinutuzumab, Questionnaire Administration and Venetoclax. Group B receives one or more of: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Obinutuzumab, Questionnaire Administration and Venetoclax.

Sites in Halifax, Montreal and 6 more cities

  • Phase 3
  • 2 groups
  • Sites in Vancouver, Winnipeg and 6 more cities
  • Recruiting

Official title: Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia · National Cancer Institute (NCI)

Get them matched to the best-fit trials

Answer a few questions and we'll find the closest matches for leukemia.

Comparing Allopurinol with Doxorubicin for b acute lymphoblastic leukemia

Explore this study →

There are 2 groups in this study. Group A, the comparison group, receives one or more of: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Bone Marrow Aspiration and Biopsy, Cyclophosphamide, Mercaptopurine, Rituximab, Thioguanine and Laboratory Biomarker Analysis. Group B receives Inotuzumab Ozogamicin, together with one or more of: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Bone Marrow Aspiration and Biopsy, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine and Laboratory Biomarker Analysis.

Sites in Calgary, Halifax and 3 more cities

  • Phase 3
  • 2 groups
  • Sites in Calgary, Winnipeg and 3 more cities
  • Recruiting

Official title: Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia · Alliance for Clinical Trials in Oncology

Comparing 3 approaches for acute myeloid leukemia

Explore this study →

There are 3 groups in this study. Group A receives Cytarabine and Venetoclax, together with one or more of: Biospecimen Collection, Bone Marrow Aspiration, Daunorubicin Hydrochloride, Echocardiography Test and Multigated Acquisition Scan. Group B receives Azacitidine and Venetoclax, together with one or more of: Biospecimen Collection, Bone Marrow Aspiration, Echocardiography Test and Multigated Acquisition Scan. Group C, the comparison group, receives Cytarabine, together with one or more of: Biospecimen Collection, Bone Marrow Aspiration, Daunorubicin Hydrochloride, Echocardiography Test and Multigated Acquisition Scan.

Sites in Montreal, Calgary and 6 more cities

  • Phase 2
  • 3 groups
  • Sites in Calgary, Edmonton and 6 more cities
  • Recruiting

Official title: Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia · National Cancer Institute (NCI)

Comparing 4 approaches for b acute lymphoblastic leukemia

Explore this study →

There are 4 groups in this study. Group A, the comparison group, receives one or more of: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Calaspargase Pegol, Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Doxorubicin Hydrochloride, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Questionnaire Administration, Radiation Therapy, Thioguanine and Vincristine Sulfate. Group B receives one or more of: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Calaspargase Pegol, Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Doxorubicin Hydrochloride, Inotuzumab Ozogamicin, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Questionnaire Administration, Radiation Therapy and Vincristine Sulfate. Group C receives one or more of: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Calaspargase Pegol, Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Leucovorin Calcium, Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Questionnaire Administration, Radiation Therapy, Thioguanine and Vincristine Sulfate. …and 1 more groups.

Sites in Saskatoon, Calgary and 13 more cities

  • Phase 3
  • 4 groups
  • Sites in Calgary, Edmonton and 13 more cities
  • Recruiting

Official title: Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia · Children's Oncology Group

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Get notified when a matching trial opens

We'll watch for Leukemia trials near you.

Leukemia
Want matched now instead? →
← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.